MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-28-2025
Ekso Bionics Holdings Total Shareholders Equity 2011-2026 | EKSO
Annual Total Shareholders Equity Ekso Bionics Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.7 M | 12.6 M | 25.4 M | 37.2 M | 4.43 M | 6.8 M | 2.73 M | 21.4 M | 6.53 M | 8.81 M | 22.8 M | -36.4 M | -25.1 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 37.2 M | -36.4 M | 7.69 M |
Quarterly Total Shareholders Equity Ekso Bionics Holdings
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.9 M | 12.7 M | 12.7 M | 14.9 M | 12.1 M | 14.1 M | 12.6 M | 15.3 M | 17.8 M | 21.3 M | 25.4 M | 28.6 M | 31.7 M | 33.5 M | 37.2 M | 39.1 M | 40.1 M | 41 M | 4.43 M | 4.43 M | 4.43 M | 4.43 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 2.73 M | 2.73 M | 2.73 M | 2.73 M | 21.4 M | 21.4 M | 21.4 M | 21.4 M | 6.53 M | 6.53 M | 6.53 M | 6.53 M | 8.81 M | 8.81 M | 8.81 M | 8.81 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M | -36.4 M | -36.4 M | -36.4 M | -36.4 M | -25.1 M | - | -4.55 K | 343 | -10.4 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 41 M | -36.4 M | 9.89 M |
Total Shareholders Equity of other stocks in the Medical instruments industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
6.96 B | $ 20.0 | -0.37 % | $ 10.2 B | USA |
 |
ICU Medical
ICUI
|
1.97 B | $ 151.75 | 1.23 % | $ 3.7 B | USA |
 |
InfuSystem Holdings
INFU
|
48 M | $ 8.23 | -0.36 % | $ 170 M | USA |
 |
Merit Medical Systems
MMSI
|
1.38 B | $ 81.02 | -0.09 % | $ 4.72 B | USA |
 |
OraSure Technologies
OSUR
|
410 M | $ 2.86 | 2.51 % | $ 213 M | USA |
 |
Alcon
ALC
|
18.8 B | $ 79.96 | -1.26 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
461 M | $ 37.42 | 1.33 % | $ 1.76 B | USA |
 |
electroCore
ECOR
|
7.44 M | $ 6.81 | 2.24 % | $ 37.6 K | USA |
 |
Haemonetics Corporation
HAE
|
821 M | $ 66.7 | 0.06 % | $ 3.36 B | USA |
 |
AngioDynamics
ANGO
|
183 M | $ 10.39 | 0.29 % | $ 424 M | USA |
 |
STERIS plc
STE
|
6.6 B | $ 263.15 | 0.21 % | $ 25.9 B | USA |
 |
The Cooper Companies
COO
|
8.24 B | $ 80.34 | -1.28 % | $ 16 B | USA |
 |
Harvard Bioscience
HBIO
|
73.1 M | $ 0.5 | -0.92 % | $ 21.2 M | USA |
 |
Glaukos Corporation
GKOS
|
462 M | $ 121.07 | 1.42 % | $ 5.86 B | USA |
 |
Isoray
ISR
|
291 M | - | 0.03 % | $ 108 M | USA |
 |
Repro Med Systems
KRMD
|
20.4 M | $ 5.48 | 1.67 % | $ 250 M | USA |
 |
iRhythm Technologies
IRTC
|
90.9 M | $ 159.57 | 3.27 % | $ 4.98 B | USA |
 |
LeMaitre Vascular
LMAT
|
337 M | $ 85.77 | 0.94 % | $ 1.93 B | USA |
 |
Utah Medical Products
UTMD
|
128 M | $ 61.06 | - | $ 222 M | USA |
 |
Masimo Corporation
MASI
|
1.05 B | $ 137.11 | -0.16 % | $ 7.31 B | USA |
 |
Intuitive Surgical
ISRG
|
16.4 B | $ 500.47 | -0.74 % | $ 178 B | USA |
 |
Microbot Medical
MBOT
|
4.5 M | $ 1.79 | -0.47 % | $ 18.3 M |  Israel |
 |
Nephros
NEPH
|
8.36 M | $ 4.26 | -1.15 % | $ 44.2 M | USA |
 |
Milestone Scientific
MLSS
|
5.83 M | $ 0.27 | -3.2 % | $ 21.5 M | USA |
 |
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
2.93 B | $ 23.4 | -0.3 % | $ 4.03 B | USA |
 |
Pro-Dex
PDEX
|
36.6 M | $ 39.56 | 0.83 % | $ 130 M | USA |
 |
Predictive Oncology
POAI
|
-203 K | - | - | $ 31.1 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.94 B | $ 12.39 | -0.64 % | $ 2.52 B | USA |
 |
Pulse Biosciences
PLSE
|
44.4 M | $ 14.07 | 1.74 % | $ 676 M | USA |
 |
Becton, Dickinson and Company
BDX
|
25.4 B | $ 202.23 | -0.61 % | $ 58.2 B | USA |
 |
Repligen Corporation
RGEN
|
1.96 B | $ 150.32 | 0.63 % | $ 8.38 M | USA |
 |
ResMed
RMD
|
3.36 B | $ 252.01 | -2.44 % | $ 36.8 B | USA |
 |
BioLife Solutions
BLFS
|
349 M | $ 22.11 | 1.42 % | $ 1.02 B | USA |
 |
Stereotaxis
STXS
|
16.3 M | $ 2.25 | 2.51 % | $ 182 M | USA |
 |
Retractable Technologies
RVP
|
87.2 M | $ 0.7 | -0.29 % | $ 21 M | USA |
 |
STAAR Surgical Company
STAA
|
397 M | $ 18.44 | -2.69 % | $ 906 M | USA |
 |
Teleflex Incorporated
TFX
|
4.28 B | $ 104.01 | -0.36 % | $ 4.87 B | USA |
 |
West Pharmaceutical Services
WST
|
2.68 B | $ 232.76 | 0.69 % | $ 17 B | USA |